Frank Hurley, Ph.D., Chairman

Dr. Frank Hurley was a co-founder of Biometric Research Institute (later known as BRI International) where he held a position of Chairman and Chief Scientific Officer until BRI's merger with Quintiles Transnational Corporation (NasdaqNM:QTRN). He served as Quintiles Chief Scientific Officer and currently is holding a position of Senior Scientist. He is also an Adjunct Professor of Biostatistics and Epidemiology at Georgetown University.

Dr. Hurley's areas of expertise include the study design, analysis and reporting to the FDA of clinical trials involving pharmaceuticals, medical devices and diagnostic products. He has a keen understanding of all phases of the regulatory approval process, including multinational clinical studies, clinical trials management and post marketing surveillance. He is a nationally recognized authority on research strategy and study design for regulatory approval.

Dr. Hurley received his BS in Mathematics from Georgetown University and his Ph.D. in Biostatistics from John Hopkins University.